Novartis AG (NYSE: NVS)

http://www.novartis.com

Novartis provides innovative healthcare solutions that address the evolving needs of patients and societies. Headquartered in Basel, Switzerland, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, eye care and cost-saving generic pharmaceuticals. Novartis is the only global company with leading positions in these areas. In 2015, the Group achieved net sales of USD 49.4 billion, while R&D throughout the Group amounted to approximately USD 8.9 billion (USD 8.7 billion excluding impairment and amortization charges). Novartis Group companies employ approximately 119,000 full-time-equivalent associates. Novartis products are available in more than 180 countries around the world. *

	Start	1996-12-20 merged
	Group	Novartis (Group)
	Industry	LIFE SCIENCES
	Person	Jimenez, Joseph (Novartis 201002–CEO before since 200704 CEO Consumer Health)
	Person 2	Kirsch, Harry (Novartis 201304– Group CFO before CFO of Novartis Pharmaceuticals)

	Region	Basel BS
	Country	Switzerland
	City	4002 Basel BS
	Tel	41 61 324 8000
		Address record changed: 2018-07-24

Basic data	Employees	J: more than 100,0 (2017-12-31)
	Currency	USD
	Annual sales	49,109,000,000 (sales, net, consolidated (2017) 2017-12-31)
	Profit	7,703,000,000 (2017-12-31)
	Cash	9,485,000 (2017-12-31)

		* Document for ï¿½About Sectionï¿½: Novartis AG. (1/27/16). "Press Release: Novartis Delivered Strong Sales Growth and Core Margin Expansion (cc[1]) in 2015, Announces Plans to Accelerate Growth at Alcon, Streamline Group Operations". Basel.

		Record changed: 2019-04-05